Holen Sie sich die Stockscreener-App
0.6414
1.01%
0.0064
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CTSO?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$0.635
Offen:
$0.66
24-Stunden-Volumen:
50,620
Relative Volume:
0.46
Marktkapitalisierung:
$40.28M
Einnahmen:
$34.35M
Nettoeinkommen (Verlust:
$-10.59M
KGV:
-3.3776
EPS:
-0.1899
Netto-Cashflow:
$-10.14M
1W Leistung:
-4.55%
1M Leistung:
-12.14%
6M Leistung:
-40.61%
1J Leistung:
-51.04%
1-Tages-Spanne:
$0.63
$0.6698
1-Wochen-Bereich:
$0.62
$0.716
52-Wochen-Spanne:
$0.60
$1.61
Cytosorbents Corp Stock (CTSO) Company Profile
Firmenname
Cytosorbents Corp
Sektor
Branche
Telefon
973-329-8885
Adresse
305 COLLEGE ROAD EAST, PRINCETON, NJ
Compare CTSO vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CTSO
Cytosorbents Corp
|
0.6414 | 39.88M | 34.35M | -10.59M | -10.14M | -0.1899 |
|
ABT
Abbott Laboratories
|
112.68 | 193.83B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
366.05 | 140.01B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
99.49 | 129.33B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.73 | 109.92B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
75.87 | 44.36B | 6.07B | 1.06B | 799.60M | 1.8527 |
Cytosorbents Corp Stock (CTSO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-09-07 | Eingeleitet | B. Riley Securities | Buy |
| 2021-10-14 | Fortgesetzt | B. Riley Securities | Buy |
| 2020-09-17 | Eingeleitet | Jefferies | Buy |
| 2020-09-01 | Eingeleitet | SVB Leerink | Outperform |
| 2017-08-08 | Bestätigt | Maxim Group | Buy |
| 2016-10-26 | Eingeleitet | Aegis Capital | Buy |
| 2016-05-24 | Eingeleitet | Maxim Group | Buy |
| 2015-10-29 | Hochstufung | WBB Securities | Speculative Buy → Buy |
| 2015-05-12 | Bestätigt | MLV & Co | Buy |
| 2015-04-01 | Bestätigt | MLV & Co | Buy |
| 2015-03-05 | Eingeleitet | MLV & Co | Buy |
| 2015-02-25 | Eingeleitet | WBB Securities | Speculative Buy |
| 2015-01-27 | Bestätigt | H.C. Wainwright | Buy |
Alle ansehen
Cytosorbents Corp Aktie (CTSO) Neueste Nachrichten
Aug PreEarnings: What makes Cytosorbents Corporation stock attractive today2025 Trade Ideas & Smart Allocation Stock Tips - baoquankhu1.vn
Rally Mode: Is Cytosorbents Corporation stock forming a cup and handleJuly 2025 Closing Moves & Trade Opportunity Analysis - baoquankhu1.vn
Trading Recap: What is CFBKs 5 year growth outlookQuarterly Risk Review & Safe Entry Point Identification - baoquankhu1.vn
CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update - BioSpace
CTSO Receives Continued 'Buy' Rating from D. Boral Capital | CTS - GuruFocus
CytoSorbents reports Q4 and full-year 2025 revenue expectations - Investing.com
CTSO Anticipates Improved Gross Margin for Full-Year - GuruFocus
Is Cytosorbents Corporation stock supported by strong fundamentalsMarket Growth Report & Verified Swing Trading Watchlists - ulpravda.ru
What hedge fund activity signals for Cytosorbents Corporation stockCEO Change & Comprehensive Market Scan Insights - ulpravda.ru
What is the fair value of Cytosorbents Corporation stock nowJuly 2025 Selloffs & Reliable Momentum Entry Alerts - ulpravda.ru
Reviewing Omeros (NASDAQ:OMER) and Cytosorbents (NASDAQ:CTSO) - Defense World
Can Cytosorbents Corporation stock deliver sustainable ROE2025 Price Action Summary & Verified Swing Trading Watchlists - ulpravda.ru
Does Cytosorbents Corporation stock trade at a discount to peersEarnings Risk Report & Consistent Profit Trade Alerts - ulpravda.ru
Trend Review: Will Cytosorbents Corporation stock maintain growth story2025 Breakouts & Breakdowns & Fast Gain Stock Tips - Улправда
Can Cytosorbents Corporation stock rebound after recent weakness2025 Biggest Moves & Risk Managed Investment Strategies - Улправда
Cytosorbents (NASDAQ:CTSO) Receives “Buy” Rating from D. Boral Capital - Defense World
CTSO: D. Boral Capital Reaffirms Buy Rating and $10 Price Target - GuruFocus
CytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday, December 15, 2025 - PR Newswire
CytoSorbents (NASDAQ: CTSO) to review $37.0M sales, DrugSorb-ATR in Dec. 15 virtual fireside chat - Stock Titan
Cytosorbents (NASDAQ:CTSO) & BioLife Solutions (NASDAQ:BLFS) Financial Comparison - Defense World
How analysts rate Cytosorbents Corporation stock todayPortfolio Update Summary & Safe Capital Investment Plans - Newser
Can Cytosorbents Corporation (HQE1) stock sustain double digit ROEJuly 2025 Recap & Long-Term Safe Investment Ideas - Newser
What technical patterns form on Cytosorbents Corporation (HQE1) stock chartsVolume Spike & Real-Time Stock Price Movement Reports - Newser
CytoSorbents (CTSO) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
How Cytosorbents Corporation stock performs in rising dollar environmentEarnings Performance Report & Verified Short-Term Plans - Newser
Is Cytosorbents Corporation a good long term investmentVolume Profile Analysis & Free Unlock Exclusive Strategies - earlytimes.in
An analyst sees good growth prospects for Cytosorbents Corp (CTSO) - Setenews
CytoSorbents reports Q3 adjusted EPS (4c), consensus (5c) - MSN
CEO Chan Buys 100,000 ($64K) Of CytoSorbents Corp [CTSO] - TradingView
Cytosorbents Corp’s Earnings Call: Growth Amid Challenges - MSN
How Cytosorbents Corporation (HQE1) stock responds to bond marketJuly 2025 Outlook & Real-Time Stock Price Movement Reports - newser.com
CTSO CEO Phillip Chan boosts stake with 100,000-share purchase - Stock Titan
Zacks Small Cap Weighs in on Cytosorbents Q1 Earnings - Defense World
Will Cytosorbents Corporation (HQE1) stock remain on Wall Street radarBull Run & Reliable Volume Spike Trade Alerts - newser.com
How buyback programs support Cytosorbents Corporation (HQE1) stockStock Surge & AI Driven Price Predictions - newser.com
CytoSorbents at Jefferies London: Strategic Growth and Regulatory Pathways - Investing.com
Is Cytosorbents Corporation (HQE1) stock a top pick for value investorsBuy Signal & Consistent Return Investment Signals - newser.com
Combining price and volume data for Cytosorbents CorporationJuly 2025 Trade Ideas & Fast Moving Stock Trade Plans - newser.com
Will Cytosorbents Corporation (HQE1) stock benefit from Fed rate cutsForecast Cut & Weekly Consistent Profit Watchlists - newser.com
Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London – Company Announcement - Financial Times
Cytosorbents’ (CTSO) Buy Rating Reiterated at D. Boral Capital - Defense World
Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London - PR Newswire
HC Wainwright Cuts Cytosorbents (NASDAQ:CTSO) Price Target to $0.75 - Defense World
Published on: 2025-11-16 10:30:06 - newser.com
Using Python tools to backtest Cytosorbents Corporation strategiesMarket Performance Report & Weekly Breakout Opportunity Watchlist - newser.com
Finanzdaten der Cytosorbents Corp-Aktie (CTSO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.33%
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):